• Tuesday,October 01,2024
gecos.fr
X

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good

$ 7.00

4.7 (518) In stock

Share

The influences of cancer types in detecting lncRNA cancer association

Non-coding RNAs as liquid biopsy biomarkers in cancer

Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment - ScienceDirect

IJMS, Free Full-Text

Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer

Frontiers Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications

Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Molecular targets with the potential as diagnostic biomarkers for

ROC analysis suggests that genomic data (the 8-lncRNA signature and a

Plumbing mysterious RNAs in “dark genome” for the conquest of human diseases - ScienceDirect

Putative consensus motifs in lncRNAs for the specific binding of key